Precigen, Inc.

NASDAQ:PGEN

Biotechnology

Healthcare
$4.16 -2.08%

-$0.10 today

Market cap
$1.49B
Beta
1.06
P/E (TTM)
-7.1
EPS (TTM)
-$0.65
52W Low $1.39High $5.47

Volume 4.37M

Average 4.72M

Price history

Precigen, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+6.67%

Period high

$8.56

Period low

$3.10

Latest

$4.16

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 5, 2026Nov 4, 2026
10-QNov 4, 2026Nov 4, 2026
4Sep 24, 2026Sep 24, 2026
4Aug 28, 2026Aug 28, 2026
4Aug 25, 2026Aug 25, 2026
4Aug 25, 2026Aug 25, 2026
4Aug 25, 2026Aug 25, 2026
4Aug 25, 2026Aug 25, 2026
4Aug 25, 2026Aug 25, 2026
4Aug 25, 2026Aug 25, 2026
4Aug 7, 2026Aug 7, 2026
SC 13G/AAug 7, 2026Aug 7, 2026
10-QAug 4, 2026Aug 4, 2026
8-KAug 4, 2026Aug 4, 2026
4Aug 3, 2026Aug 3, 2026

Competitors

Who does Precigen, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about PGEN's filings, answered from its disclosures.

What is the latest PGEN filing?

The latest filing shown is 8-K dated Nov 5, 2026.

How many recent filings does PGEN have?

Intrinsic Alpha currently shows 20 recent filings for PGEN.